Fighting a disease through targeting its pathophysiologies is, in a sense, an attempt to outflank it rather than attack it head-on. Instead of looking for the magic bullet that will kill the virus, or the tumor, it’s about making the body an unfriendly place for the disease to be in.
The main advantage to this approach is that there already exists a formidable arsenal to assist in this fight: 9500 drugs approved worldwide.
“We believe that in the bank of drugs we have now, the 9500 drugs there are in the world, we have the answers for virtually all diseases. Around 500 of them are still patented. So there’s opportunity to work through the other 9000 off-patent drugs — the generic drugs — and look at the impact that 1 can have for $1 a day.”
Cureosity is a repository of manually curated knowledge about novel treatments for serious, chronic, and intractable diseases.